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KESAN PENGAWALATURAN IMUN EKSTRAK PROPOLIS DARI 
Geniotrigona thoracica sp. KE ATAS PEMBENTUKAN SEL BUSA 
MAKROFAJ DIPEROLEH DARIPADA SEL THP-1 
 
ABSTRAK 
 Propolis adalah bahan resin kompleks yang dikumpulkan oleh lebah dari 
tunas dan eksudat tumbuhan yang telah dilaporkan untuk menunjukkan pelbagai 
potensi terapeutik. Penggunaan produk semulajadi seperti propolis telah digunakan 
untuk rawatan pelbagai penyakit kronik seperti aterosklerosis. Aterosklerosis adalah 
penyakit radang kronik yang membabitkan pembentukan sel busa makrofag daripada 
monosit di dalam arteri, yang memainkan peranan penting dalam aterogenesis. Banyak 
kajian menunjukkan bahawa propolis yang dihasilkan oleh lebah madu boleh merencat 
pembentukan aterosklerosis tetapi masih tiada kajian yang dilakukan menggunakan 
propolis yang dihasilkan oleh lebah Indo-Malayan. Oleh itu, kajian ini dijalankan 
untuk mengkaji kesan propolis daripada spesies Geniotrigona thoracica pada 
pembentukan sel busa yang terlibat dalam atheroscelrosis. Ekstrak etanol propolis 
(EEP) daripada tiga koloni lebah dari spesies Geniotrigona thoracica yang berbeza 
dikumpulkan dan diekstrak menggunakan etanol 80%. Pelbagai sebatian yang tidak 
menentu yang terdapat dalam ekstrak propolis dianalisis melalui analisis GC-MS dan 
HPLC. Kepekatan optimum propolis ekstrak (0-200 μg/ml) untuk merawat makrofaj 
diperoleh daripada sel THP-1 ditentukan melalui ujian in vitro daya kehidupan sel 
dengan menggunakan reagen PrestoBlue®. Sel THP-1 dibezakan dengan makrofag 
yang diperoleh daripada sel THP-1 menggunakan 100 ng/ml PMA selama 72 jam. 
Kemudian, makrofag yang diperoleh daripada sel THP-1 dirawat dengan 80 μg/ml 
LDL teroksida dan 20 μg/ml EPP selama 6, 24 dan 48 jam. Penampilan morfologi sel 
 xiii 
 
buih ditentukan menerusi pewarnaan oil red O manakala jumlah ester kolesterol yang 
terdapat di dalam sel-sel buih dianalisis dengan menggunakan Kit Sokongan 
Kuantifikasi Kolesteril Ester. Akhirnya, tahap rembesan sitokin keradangan iaitu TNF-
α dan IL-1β yang dirembes oleh sel-sel yang dirawat diukur oleh ELISA. EEP dari 
spesis Geniotrigona thoracica didapati mengandungi banyak sebatian triterpenoids 
dan kehadiran asid kafein, asid p-Coumaric dan sebatian quercetin berdasarkan 
analisis GC-MS dan HPLC. Propolis dari koloni 2 dipilih untuk digunakan dalam 
kajian ini kerana ia mempunyai lebih banyak sebatian bioaktif.  𝐸𝐶90 EEP ditentukan 
berada pada kepekatan 20 μg/ml dan kepekatan ini digunakan untuk eksperimen 
berikutnya. Pemerhatian morfologi menunjukkan bahawa butiran lipid kelihatan 
berkurang di sitosol sel makrofag yang diperoleh daripada THP-1 yang dirawat 
propolis dan LDL teroksida. Di samping itu, kandungan ester kolesteril telah 
berkurangan secara signifikan dalam sel makrofaj yang diperoleh daripada THP-1 
yang menerima perawatan propolis dan LDL teroksida pada setiap masa rawatan. 
Selain itu, EEP juga didapati dapat mengurangkan dengan ketara rembesan sitokin 
TNF-α dan IL-1β dalam supernantan propolis dan LDL teroksida yang dirawat THP-
1 yang diperolehi makrofaj. Sebagai kesimpulan, EEP dari spesis Geniotrigona 
thoracica  menghalang pembentukan sel busa makrofag yang berasal dari sel THP-1 
dengan menghalang rembesan TNF-α dan IL-1β yang biasanya dirembes secara 
banyak semasa pembentukan aterosklerosis. 
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IMMUNOREGULATORY EFFECT OF ETHANOLIC EXTRACT 
PROPOLIS (EEP) FROM Geniotrigona thoracica sp. ON THE FORMATION 
OF THP-1 DERIVED MACROPHAGE FOAM CELLS 
 
ABSTRACT 
Propolis is a complex resinous substances collected by bees from buds and 
exudates of plants that has been reported to demonstrate various therapeutic potential. 
The usage of natural product such as propolis has been used for treatment of various 
chronic diseases which includes atherosclerosis. Atherosclerosis is a chronic 
inflammatory disease involving the formation of monocyte derived macrophage foam 
cells in arteries, which play a major role in atherogenesis. Studies showed that propolis 
produced by honeybees may inhibit atherosclerosis but there is no studies that have 
been performed using propolis produced by Indo-Malayan stingless bees. Hence, this 
study was carried out to investigate the effect of propolis from Geniotrigona thoracica 
species on the formation of foam cells. Propolis from three different colonies of 
Geniotrigona thoracica species were extracted using 80% ethanol. The volatile and 
non-volatile compounds present in ethanolic extract of propolis (EEP) were analysed 
via GC-MS and HPLC analysis. The optimal concentration of EEP (0-200 µg/ml) to 
treat THP-1 derived macrophages was determined via in vitro cell viability assay by 
using PrestoBlue®. THP-1 cells were differentiated to THP-1 derived macrophages 
using 100 ng/ml of PMA for 72 hours. Then, THP-1 derived macrophages were treated 
with 80 µg/ml of oxidized LDL (oxLDL) and 20 µg/ml of EEP for 6, 24 and 48 hours. 
The morphological appearance of foam cells was determined by Oil Red O staining 
while the amount of cholesteryl ester (CE) present in the foam cells were quantified 
by using Cholestryl Ester Quantitation Assay Kit. Lastly, the level of inflammatory 
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cytokine secretions, TNF-α and IL-1β secreted by the treated cells were measured by 
ELISA. Propolis extract of Geniotrigona thoracica sp. was found to have high 
abundance of triterpenoids and the presence of caffeic acid, p-Coumaric acid and 
quercetin compounds via GC-MS and HPLC analysis respectively. EEP from Colony 
2 was selected to be used in this study as it has higher abundance of bioactive 
compounds. The 𝐸𝐶90 of EEP was determined to be at 20 µg/ml and this concentration 
was used for subsequent experiments. Morphological observation showed that lipid 
droplets were reduced in the cytosol of propolis and oxLDL treated THP-1 derived 
macrophages. Similarly, CE contents were significantly reduced in the combination of 
oxLDL and EEP treated THP-1 derived macrophages at all time points. In addition, 
EEP also was found to significantly reduced TNF-α and IL-1β secretions in the 
supernatant of the combination of oxLDL and EEP treated THP-1 derived 
macrophages. As a conclusion, EEP from Geniotrigona thoracica sp. inhibit the 
formation of THP-1 derived macrophage foam cells by suppressing secretion of     
TNF-α and IL-1β which normally be up-regulated during the pathogenesis of 
atherosclerosis. 
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CHAPTER 1  
LITERATURE REVIEW 
1.1 Atherosclerosis 
Atherosclerosis is a chronic inflammatory disease of the arteries initiated by 
the retention, oxidation and modification of lipid occur at susceptible sites in major 
conduit arteries (Insull, 2009). Atherosclerosis is a disease characterized by the 
deposition of excessive fatty acid substances in the arterial intima. The deposition of 
the of the fatty acids also known as plaque are made up of lipid, cholesterol, calcium 
and other substances found in the blood stream that causes the arteries to become 
harden and narrow as the plaque builds up progressively. Atherosclerosis develop 
progressively through the continuous changes of the arterial wall lesions accompanied 
with complex inflammatory response. This alarming condition will restrict the flow of 
blood to vital organs such as heart, brain as well as other parts of the body, which 
eventually leads to cardiovascular diseases (CVDs) such as myocardial infarction, 
ischemic stroke, deep vein thrombosis and pulmonary embolism (Sundbøll et al., 
2017). Cardiovascular disease (CVD) is the name for the group of disorders of the 
heart and blood vessels.  
 
1.1.1 Epidemiology and risk factor of atherosclerosis 
According to World Health Organization (WHO), in 2017, CVDs are the 
number one cause of death globally followed by cancer, respiratory diseases and 
diabetes. It is estimated that 17.7 million people died from CVDs in 2015 that represent 
31% of all global deaths, which account for 7.4 million deaths that were due to 
coronary heart disease and 6.7 million deaths due to stroke. In addition, according to 
American Heart Association, the number of people diagnosed with heart failure is 
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projected to rise by 46 percent by 2030 due to the global increase in diabetes and 
obesity problems. In developing countries, CVDs cause twice as many deaths as HIV, 
malaria and TB combined. It is also estimated that about 40 to 50% of all 
cardiovascular deaths are sudden cardiac deaths (SCDs) and the survival rate form 
sudden cardiac arrest is less than 1% worldwide and close to 5% in the US (Mehra, 
2007; Rahman and Woollard, 2017). In Malaysia, the cardiovascular disease epidemic 
showed that two third of the population in this country had at least one cardiovascular 
risk factor and at least one third had two or more risk factors (Nuur Amalina et al., 
2012). There are two known risk factors of atherosclerosis, which are life styles and 
conditions. Life styles includes cigarette smoking, unhealthy diet and alcohol 
consumption (Patel and Rutherford, 2017). On the other hand, for conditions, there a 
few conditions that can lead to atherosclerosis such as high cholesterol content in 
blood, high level of low density lipoprotein (LDL), insulin resistance, hyperglycemia 
(high blood sugar), high blood pressure and obesity (Christou et al., 2005; Tian et al., 
2010). Apart from that, according to current research by Gupta et al., 2013, there are 
also several emerging risk factors of atherosclerosis such as C-reactive protein (CRP), 
fibrinogen and homocysteine.   
 
1.1.2 Pathogenesis of atherosclerosis (atherogenesis) 
Atherosclerosis is characterized by several events including endothelial 
dysfunction, vascular inflammation and the accumulation of modified lipid, 
inflammatory cells and cell debris in plaques within the vascular wall. Endothelial 
cells, leukocytes and intimal smooth muscle cells (Glass and Witztum, 2001).  
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1.1.2(a)  Endothelial dysfunction or injury 
A normal and healthy artery consists of three distinct layers, which are tunica 
intima, tunica media and tunica adventitia (Gimbrone and García-Cardeña, 2013) 
(Figure 1.0a). Tunica intima or also known as endothelial cell (EC) layer is a 
monolayer of endothelial cells that lines the lumen of all blood vessels. Tunica media 
is the central layer of vascular smooth muscle cells (VSMC), elastin fibers and 
extracellular connective tissue (proteoglycans and collagen) matrix that control 
vascular tone. Meanwhile, tunica adventitia is the surrounding layer of connective 
tissue, containing mast cells, dendritic cells, monocytes/macrophages, T cells and 
micro-vessels or vaso vasorum that provide nutrition to arteries and veins that is related 
to perivascular adipose tissue which is a vital site for inflammation and angiogenesis 
(Douglas and Channon, 2014). Endothelial cells that layers the intima function as 
interface between circulating blood and the rest of the vessel wall and any changes in 
EC phenotype will affect the function of the arteries via the regulation of Nitric Oxide 
(NO) which is one of the most significant signaling molecules produced by the 
endothelium (Bauer and Sotníková, 2010). Nitric oxide play an important role in 
inducing vasodilation in response to platelet aggregation, reducing adhesion molecules 
expression to prevent macrophage infiltration and slows the proliferation of VSMC 
which are protective against atherosclerosis (Vanhoutte, 2009).  
The EC dysfunction occurs by several mechanisms such as free radical 
oxidation (Vanhoutte, 2009). The dysfunctional EC will reduce the production of NO 
and increased generation of reactive oxygen species (ROS) or superoxide radicals. The 
synergistic interaction between NO and ROS will form peroxynitrite (ONOO−) that 
cause damage to proteins and lipids in the arteries leading to alteration of vascular 
integrity, reduction of vasodilator capacity and appearance of endothelial dysfunction 
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(Douglas and Channon, 2014). Excess production of ROS is highly pathological and 
relates directly to atherogenesis.  
 
1.1.2(b)  Fatty streaks formation 
An increase in the level of low density lipoprotein (LDL) cholesterol is one of 
the most prominent risk factor in atherosclerosis. LDL is responsive to oxidation by 
enzymes namely myeloperoxidases, lipoxygenases, NADPH oxidases and nitric oxide 
synthases resulting in the formation of oxidised LDL (oxLDL)  (Tsimikas and Miller, 
2011). OxLDL display a cytotoxic effect where it activate and cause injury to the 
endothelial resulting in an inflammatory response that leads to recruitment, activation 
and migration of monocytes through inter-endothelial gaps to the sub-endothelial 
region or arterial intima (Ross, 1999). OxLDL cause endothelial activation via 
induction of cell surface adhesion molecules, monocyte chemo attractant protein-1 
(MCP-1) that mediates the attraction and attachment of monocytes (Chen and 
Khismatullin, 2015). 
 Apart from that, oxLDL also stimulates EC to increase the expression of 
vascular adhesion molecules-1 (VCAM-1) and intracellular adhesion molecules-1 
(ICAM-1) that binds to the cell surface receptor of monocytes for adhesion and 
recruitment (Kim et al., 2001) (Figure 1.0b). According to Lawrence, 2009 , oxLDL 
was found to activate the generation of nuclear factor kappa B (NF-kB) that is 
important in modulating expression of pro-inflammatory cytokines (TNF-α, IL-1β), 
adhesion molecules and chemokines that take part in pathogenesis of atherosclerosis. 
In tunica intima, blood circulating monocytes undergo differentiation into 
macrophages under the influenced of macrophage-colony-stimulating-factor (MCSF) 
as it promotes synthesis of scavenger receptor protein on the surface of the monocytes 
(Hume and MacDonald, 2012). The differentiated macrophages then will ingest 
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oxLDL via endocytosis by CD36 scavenger receptor (Silverstein and Febbraio, 2009) 
resulting in transformation of macrophages into foam cells. The accumulation of foam 
cells will lead to fatty streaks formation which is the first stage in atherosclerotic 
plaque development (McLaren et al., 2011). Foam cells contain a massive amount of 
oxLDL that is composed of esterified cholesterol and triglycerides together with the 
fatty acids tails of the phospholipid.  
 
1.1.2(c) Atherosclerotic plaque and thrombosis 
Atherosclerotic inflammation causes macrophages to be trapped in the lesion 
as macrophage loss its polarity induced by oxLDL via the activation of Vav/Rac 
pathway (Chi and May, 2009). Several cell types including SMC, EC, macrophages, 
monocytes and platelets play a pivotal role in atherosclerotic plaque stability. The 
plaque is located beneath a fibrous cap of extracellular matrix (ECM) and VSMC and 
its stability depends on the unimpaired connection between endothelium and fibrous 
cap that isolate the atherosclerotic lesion from the circulating blood as shown in Figure 
1.0c (Douglas and Channon, 2014). In contrast, the plaque will become unstable due 
to a vast changes in cellular composition and structure causing a mechanical weakness 
to the fibrous cap leading to platelet aggregation and thrombus formation (Badimon 
and Vilahur, 2014) (Figure 1.0d). The characteristic of an unstable atherosclerotic 
plaque include a large lipid core, thin fibrous cap that contain high ratio of 
macrophages to VSMC and reduced collagen content. These characteristic of unstable 
plaque are due to the increased in secretion of pro-inflammatory cytokines and the 
generation of matrix metalloproteinases (MMPs) that degrade collagen produced by 
VSMC in the fibrous cap causing it to become thinner which then lead to thrombosis 
(Rundhaug, 2005) 
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Figure 1.0: Stages in the development of atherosclerotic lesions. a) The normal 
artery contains three layers namely tunica adventitia, tunica media and tunica 
intima. b) Atherogenesis initiated by the adhesion of blood leukocytes to activated 
endothelial monolayer, facilitate the migration of bound leukocytes into the 
intima, maturation of monocytes into macrophages, and their uptake of lipid 
which convert the mature macrophages into foam cells. c) Lesion progression 
involves the migration of SMC from media to intima, the proliferation of SMC 
and the increased in synthesis of extracellular matrix macromolecules. 
Extracellular lipid derived from dead and dying cells can accumulate in the central 
region of a plaque denoted as necrotic core. d) Thrombosis caused physical 
disruption of the atherosclerotic plaque as the burst of the plaque’s fibrous cap 
will cause blood coagulation components to come into contact with tissue factors 
in the plaque’s interior causing the thrombus to extend into vessel lumen that can 
block blood circulation (Libby et al., 2011).  
 
 
 
 
 
 
 
 
 
 
1.0a 1.0b 
1.0d 1.0c 
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1.1.2(d) Current treatment of atherosclerosis 
Atherosclerosis is a multi-factorial inflammatory disease and there are various 
approaches that have been studied and attempted for its prevention and treatment. The 
strategies used to combat atherosclerosis include lipid lowering drug, anti-
inflammatory drug and natural or herbal remedies. The usage of lipid lowering drug 
namely Statin exhibit anti-inflammatory mechanism that help in reducing cholesterol 
synthesis by inhibiting HMG-CoA reductase enzyme involve in cholesterol production 
(Charo and Taub, 2011). Although statin has been used widely throughout the globe 
for the treatment of atherosclerosis, there is a side effect reported as it can induced 
rhabdomyolysis that damages skeletal muscle which is life threatening (Sakamoto and 
Kimura, 2013). 
On the other hand, herbal medicines have been traditionally used since ancient 
time for treatment of various chronic diseases by indigenous herbal practitioners. 
Herbal extracts or a combination of several herbal supplements are prescribed to 
patients to improve therapeutic efficacy (Zeng et al., 2012). Herbal plants contain a 
variety of chemical constituents that work individually or synergistically which 
contribute in increasing or inhibiting the desired effect for a particular disease 
(Sasidharan et al., 2011). There are various studies conducted in relation of using 
natural products for the prevention and treatment of atherosclerosis and among them 
is the usage of propolis. Propolis has attracted interest of researchers all over the world 
due to the potency of its biological properties such as anti-inflammatory and anti-
atherogenic. 
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1.2  Propolis: The properties and chemical composition 
Propolis is the term used to describe the sticky resinous material collected by 
variety species of bees. It is also generally known as bee glue comprises of exudates 
or young shoots and bud of certain plants collected at the surrounding of bee hive that 
are mix together with wax and bee enzyme (Bankova et al., 2014). The plants secrete 
the sticky substances in order to coat the young shoots and buds to protect them from 
abysmal weather as well as from the attack by bacteria, fungi, molds and viruses 
(Sahinler and Kaftanoglu, 2005). Depending on the origin of the propolis, the color 
varies from green, red to dark brown with a characteristic smell and shows adhesive 
properties (Burdock, 1998). Propolis in its natural from is shown in Figure 1.1. 
 
 
 
 
 
 
 
Propolis serve a variety of functions that benefit both the bee’s colony and its 
hive. The bees collect the resinous substances, transport them using their hind legs, 
and bring it back to their hive. The propolis will then help to cover cracks and crevices 
to smooth out the internal walls in the hive as well as reducing the size of the hive 
entrance to prevent large insects such as butterflies, beetles and moths to enter 
(Denisow and Denisow-Pietrzyk, 2016). Apart from that, propolis also was used to 
Figure 1.1: Propolis sample of Geniotrigona thoracica sp. 
before being harvested 
Propolis 
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seal holes in their honeycombs in order to protect the bee’s colony and larvae from 
pathogenic microorganism such as bacteria and fungi thus helps in maintaining their 
longevity (Sforcin, 2007). Propolis also function as thermal isolation as it help in 
keeping the temperature and moisture in the hive at an optimal level throughout the 
year (Huang et al., 2014). Last but not least, bees also use propolis to cover carcasses 
of hive invaders such as ants that have died inside the hive to prevent their 
decomposition which can harm the bees with presence of decomposers in the hive 
(Burdock, 1998). The word propolis was originated from the combination of two 
Greek words which are ‘Pro’ that means in defense, and ‘Polis’ which means city that 
subsequently reflect the importance and function of the propolis itself. 
Bees modify propolis by using glucodiases enzyme secreted from 
hypopharyngeal glands during collection and processing. The specific enzymatic 
modification towards propolis resulted in the hydrolyzation of phenolic compounds 
like flavonoid heterosides to free flavonoid aglycones and sugars that further enhance 
the pharmacological action of propolis   (Najafi et al., 2007). 
Besides that, propolis has long been used extensively as medicine since ancient 
times in many parts of the world. Propolis also was recognized by the Greek and 
Roman physicians including Aristoteles, Dioscorides, Pliny and Galen for its 
beneficial medicinal properties towards human being. According to Aristoteles, 
propolis was referred as a substance which the bees smeared at the hive entrance and 
used as a cure for bruises and sores (Bogdanov and Stefan, 2014). In the Middle East, 
propolis was used among Arab physicians as an antiseptic and cicatrizant in wound 
treatment as well as mouth disinfectant due to its potent anti-bacterial properties. In 
addition, the London pharmacopoeias of the seventeenth century had listed propolis as 
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an official drug to be used for medicinal purposes and it became very popular in Europe 
due to its anti-bacterial activity (Castaldo and Capasso, 2002). 
Apart from that, propolis possesses a wide range of biological and 
pharmacological properties that has been significantly reported all over the world such 
as immunomodulatory (Chan et al., 2013) , anti-inflammatory (Naito et al., 2007), 
antioxidant (Kurek-Górecka et al., 2014), antibacterial (Oliveira et al., 2010), antiviral 
(Schnitzler et al., 2010) and antifungal (Ota et al., 2001). Therefore, due to the vast 
medical attributes that propolis showcase, it is currently used as a popular remedy in 
variety of form such as capsules, extract, mouthwash, in throat lozenges, creams and 
powder to be used by a wider range of health conscious consumer all over the world 
(Castaldo and Capasso, 2002). The wide application of propolis in modern medicine 
has drawn attention and pique interest of researchers to investigate its chemical 
constituents that contribute to its biological properties.   
 There are numerous research conducted about propolis and its respective 
compounds up to this day. There were more than 250 individual compounds that have 
been established as the constituents of propolis. Natural or raw propolis composed of 
approximately 50% resin and plant balsam, 30% wax, 10% essential and aromatic oils, 
5% pollen and other organic substances. The organic substances present in raw 
propolis include vitamins, minerals, sugars, alcohols and amino acids (Salatino et al., 
2005; Huang et al., 2014).  In addition, the usage of separation and purification 
techniques such as High Performance Liquid Chromatography (HPLC) and Gas 
Chromatography Mass Spectrometry (GC-MS) allow more compounds to be identified 
in propolis extract including flavonoids, terpenes, phenolics, sugars and hydrocarbons 
(Huang et al., 2014). Furthermore, among these organic compounds, phenolics, 
flavonoids and esters are found to be the most abundant compound present in all their 
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forms in propolis extract. Chemically, flavonoids compound present in propolis are 
flavones, flavonoles, flavonones, dihydroflavonoles, isoflavones, neoflavonoids and 
chalcones. Meanwhile, phenolic compounds include phenolic aldehydes and phenolic 
derivatives of cinnamic and benzoic acid such as caffeic acid esters, terpenes, steroids,  
sesquiterpenes, naphthalene and stilbene terpenes (Marcucci et al., 2001; Najafi et al., 
2007).  
Phenolic compounds are substances that are found mainly in fruits as they 
contribute to its color and taste. Chemically, phenols are made up of an aromatic ring 
bound with one or more hydrogenated substituents including their functional 
derivatives (Izawa et al., 2011). Phenolic compounds comprises of a variety of groups 
including phenolic acids, phenolic aldehydes, benzoic and cinnamic acid and their 
derivatives, coumarins and phenols and their esters. The most common derivatives of 
benzoic and cinnamic acid are caffeic acid and p-Coumaric acid respectively (Kurek-
Górecka et al., 2014). Not just that, phenolic compounds in their variety of forms are 
reported to be responsible for many biological attributes such as antioxidant (Chirinos 
et al., 2013), antibacterial (Inui et al., 2014), anti-inflammatory (Park, 2011) and anti-
atherogenic properties (Daleprane et al., 2012) 
 Flavonoids are a group of natural compounds synthesized via phenylpropanoid 
pathway that are found ubiquitously in plants. The chemical structure of flavonoids 
consists of a 15-carbon skeleton consisting of two benzene rings (A and B as shown 
in Figure 1.2 linked via a heterocyclic pyrane ring (C). Flavonoids can be divided into 
different classes that differ in the level of oxidation and pattern of substitution of the 
A and B rings. The different classes of flavonoids are flavones such as apigenin and 
luteolin; flavonols such as quercetin, kaempferol, myricetin and fisetin; flavonones 
such as hesperetin and naringenin (Kumar and Pandey, 2013).  
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As one of the major constituents of propolis, flavonoids play a major role in 
the biological properties of propolis. It was reported that flavonoids contribute to the 
activities such as antibacterial (Cushnie and Lamb, 2011), antiviral (Özçelik et al., 
2011) and anti-inflammatory (Pan et al., 2010). Flavonoids also was found to have 
protective effect against degenerative diseases such as cardiovascular diseases (CVDs) 
and cancers (Cook and Samman, 1996). Flavonoids was reported to display 
antiatherogenic effects by breaking the chain reaction of lipid oxidation initiated by 
free radicals which help to protect lipoprotein from being oxidized thus reduce the risk 
factor of atherosclerosis (Kurek-Górecka et al., 2014). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Chemical structure of flavonoids. The chemical structure of 
flavonoids consists of a 15-carbon skeleton consisting of two benzene 
rings (A and B as shown in Figure 1.2 linked via a heterocyclic pyrane 
ring (C).  (Kumar and Pandey, 2013) 
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1.2.1 Biological activities of propolis and its contributing constituents 
There were numerous study on biological properties of propolis. The biological 
properties such as immunomodulatory, anti-inflammatory, antioxidant, antibacterial 
and antiviral are among those that had been reporetd. The wide application of propolis 
is due to its biological attributes that might be the result of synergistic action of its 
complex constituents such as flavonoids, phenolic, terpenoids, steroids, amino acids 
and many other constituents (Huang et al., 2014) as shown in Table 1.0.   
 
 
 
Activity Constituent 
Antimicrobial Terpenes: diterpenes, triterpenes 
Antibacterial Chrysin, apigenin, pinocembrin and galangin 
Antiviral (anti-influenza 
virus and anti-herpes 
simplex virus type 2) 
Polyphenols, flavonoids, phenyl-carboxylic acids and 
esters of substituted cinnamic acids (caffeic acid, p-
coumaric acid, benzoic acid, galangin, pinocembrin). 
Anti-oxidant Caffeic Acid Phenolic Ester (CAPE), caffeic acid, 
quercetin, kaempferol, luteolin, chrysin, propolins, 
polyisoprenylated benzophenone, artepillin C, 
caffeoylquinic acid derivatives. 
Anti-inflammatory CAPE, quercetin, chrysin 
Immunomodulatory CAPE 
Hepatoprotective CAPE, chrysin, diterpenes 
Cardioprotective CAPE, acacetin, chrysin, quercetin 
Anticancer CAPE, artepillin C, chrysin, quercetin, propolin C  
Antitumor Artepillin C, caffeic acid, CAPE, quercetin, cinnamic 
acid derivatives, baccharin, drupanin, propolins 
Anti-ulcer Caffeic, ferulic, p-coumaric and cinnamic acids, 
essential oil 
Table 1.0: Biological activities of propolis and contributing constituents (Farooqui 
and A Farooqui, 2010). 
 
 14 
 
1.2.2  Variation in propolis properties from different geographical region 
Propolis possess remarkable biological properties due to its vast chemical 
compositions and both of the factors directly correlates with the geographic location 
or site where the propolis are produced. This is due to the fact that in different 
ecosystem, stingless bees collect resins from different type of plants with respect to 
the local flora in that particular area (Bankova et al., 2014). Chemical studies 
performed on propolis to identify their specific chemical constituents from different 
geographical region also show a high degree of variability (Bankova, 2009). For 
instance, in temperate zones such as Europe, North America and the non-tropical 
regions of Asia, the main source of plants used for bees to produce propolis are from 
the bud exudates of Populus species or poplar trees and their hybrids (Greenaway et 
al., 1987; Bankovana et al., 2000). However, in tropical regions, poplar trees do not 
grow in the climate, hence the stingless bees must find other alternatives to produce 
propolis. For instance, in Venezuela, stingless bees used Clusia major and Clusia 
minor (Guttiferae) as the primary sources of exudates to generate propolis which is 
definitely different with the sources used in temperate regions (Tomás-Barberán et al., 
1993).   
The difference in the source of plants used by stingless bees have shown to 
affect the chemical composition of the propolis itself. Propolis from Europe and 
Argentina contain high levels of chrysin, pinocembrin, pinobaksin-acetate and 
galangin (Gardana et al., 2007). Meanwhile, propolis originated from Taiwan and 
Japan are highly abundant with propolins and prenylated falvonone compounds (Chen 
et al., 2004; Kumazawa et al., 2007). The differences in chemical composition caused 
difficulties in the standardization of propolis extract. Hence, according to Bankova, 
2005 the biological properties of each propolis must be determined based on its 
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detailed investigation of chemical composition and to its related botanical sources. In 
addition, comparative studies have proven that propolis always exemplify similarities 
in its biological activity regardless of their differences in chemical composition (Seidel 
et al., 2008).  
 
 
Propolis type Geographical origins Plant source 
Poplar Europe, North America, 
Bulgaria, Albania, South Brazil, 
Argentina, Uruguay, Mongolia 
non-tropic regions of Asia, New 
Zealand 
Populus sp. of section 
Aigeiros, P. italic, P. tremula, 
P. suaveolens, P. fremontii,   
P. euramericana, P. alba,  
Green (alecrim) 
Brazilian 
Brazil Baccharis sp. predominantly  
B. dracunculifolia  
Birch Russia, Hungary and Poland Betula verrucosa  
Red propolis Cuba, Brazil (type 13 
Brazillian, northeast Brazil) and 
Mexico 
Dalbergia sp.  
Mediterranean Sicily, Greece, Crete, Malta Cupressaceae  
(species unidentified) 
Clusia Cuba, Venezuela and other 
equatorial regions 
Clusia sp. or Clusia minor 
Pacific Pacific region (Okinawa, 
Taiwan, Indonesia) 
Macaranga tanarius 
 
 
 
 
 
Table 1.1: Most widespread propolis type, geographical origins and their plant 
sources  (Sforcin and Bankova, 2011; Toreti et al., 2013). 
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1.2.3 Diversity of stingless bees species in Malaysia 
Stingless bees belong to a large group of bees in the subfamily of Apidae in the 
Meliponi tribe of the Hymenoptera order of insects. Stingless bees are social bees that 
are able to produce propolis collected from buds and exudates of plants and honey by 
collecting and storing nectar in a honey pot. There are more than 500 species of 
stingless bees that have been identified globally (Kelly et al., 2014). The stingless bees 
are prone to be found in tropical countries such as Malaysia, Brazil, Cuba, Venezuela 
and Cambodia. The stingless bees species that are found in Malaysia varies between 
17 to 32 species that are closely related with the area of study (Salim et al., 2012). The 
species that can be found in Malaysia are Trigona itama, Trigona thoracica, Thrigona 
apicalis, Trigona terminata, Trigona respani, Trigona melanocephala, Trigona 
valdezi, Trigona collina, Trigona atripes, Trigona canifrons, Trigona iridepennis and 
Trigona rufibasalia (Mohd et al., 2010).  
The cultivation or beekeeping of stingless bees are commonly known as 
meliponiculture, which are done for commercialization purposes. The stingless bees 
sp. that are most widely used in meliponiculture in Malaysia are T. thoracica and T. 
itama (Kelly et al., 2014). In Malaysia, meliponiculture are extensively done 
throughout the nation and the industry was already a 200 million ringgit a year in profit 
(Mohd Saufi and Thevan, 2015). Each stingless bees hive produced about 1.5 kg to 2.0 
kg of honey per month that are sold between RM150 to RM 200 per kilogram. The 
bee’s hives also is a source of propolis and beebread, which had been used 
commercially in the health and cosmetics industries (Iryani and Ismail, 2016). 
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Figure 1.3: Geniotrigona thoracica sp. of stingless bee 
morphology  
1.2.4 Characteristics and behavior of Geniotrigona thoracica sp. of stingless bees 
Geniotrigona thoracica sp. of stingless bees are noticeably small, about 2 to 
14 mm long with relatively absence of hair and round shape abdomen. It is black in 
color with four membranous transparent brownish wings and buccal parts that form a 
tongue-like structure which function in food intake. It also has a highly modified hind 
leg similar to T. itama sp. with atrophied sting but the bees are highly likely to bite if 
their nest is disturbed (Sakagami and Inoue, 1989). Geniotrigona thoracica sp. of 
stingless bees are active all year round collecting nectar and pollen from different 
plants (Biesmeijer et al., 2006). Apart from that, every species of stingless bees has 
specific nest preferences according to their sizes, population and habitat quality 
(Couvillon et al., 2008). Geniotrigona thoracica sp. of stingless bees are prone to make 
a nest at a tree with a trunk circumference ranging from 82 cm to 129 cm. The nest 
entrance of stingless bees that are found to be enhance with propolis are also different 
depending on species as it function in physical defense against invaders and physio-
chemical regulation (Lima et al., 2013). Geniotrigona thoracica sp. of stingless bees 
form a mount-shape entrance with the widest entrance compared to all other species 
with a length 3.97 cm and 4.0 cm in width.  
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1.3 Immunomodulatory action of propolis 
Propolis possess anti-atherogenic and anti-inflammatory activities that is 
related to the progression of atherosclerosis. According to Orsatti et al., 2010, propolis 
has shown to exert an effect or influence on the immune system particularly during 
inflammation. Propolis demonstrate anti-atherogenic properties by down-regulating 
pro-inflammatory cytokines such as MCP-1, IFN-γ, IL-6, TGF-β and VCAM-1 
expression in both initial atherosclerotic lesions and advanced atherosclerotic lesions 
mice (Daleprane et al., 2012). Cytokines play a very important role in enhancing the 
local inflammatory response, which promotes the progression of atherosclerotic 
lesions. Hence modulating cytokines expression that involve in inflammation process 
is the key to prevent atherogenesis. Other than that, MMPs which is known as one of 
the most important angiogenic biomarkers in atherosclerotic plaque development is 
 
Figure 1.4: The nest entrance of Geniotrigona 
thoracica sp. of stingless bees in the shape of 
mount. 
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shown to be significantly down-regulated by propolis that can be seen in the decreased 
in atherosclerotic lesion in both group of treated mice (Daleprane et al., 2012).  
Besides that, propolis exert anti-inflammatory activity by suppressing the gene 
activation of NO synthase and TNF-α mediated NF-ĸB activation through the presence 
of caffeic acid phenetyl ester (CAPE) which is one of the active constituents of 
propolis (Farooqui and Farooqui, 2010; Márquez et al., 2004; Song et al., 2002). CAPE 
inhibits the enzyme activities of COX-1 and COX-2 and suppresses the transcriptional 
expression of COX-2, resulting in diminished synthesis of prostaglandins, major 
mediator of inflmammation. Apart from that, CAPE was found to exert its inhibitory 
effect on NF-ĸB by reducing the reactive oxygen intermediates production that is 
needed for NF-ĸB activation (Natarajan et al., 1996). Propolis was reported to exert 
immune response through macrophage activation by inducing the release of hydrogen 
peroxide and reduce NO production by inhibiting inducible NO synthase (i-NOS) 
expression and its catalytic activity (Araujo et al., 2012). 
 
1.4  THP-1 cell line application in immune modulation approach 
THP-1 cell is a human leukemia monocytic cell line that was isolated from the 
whole blood of a 1 year old boy that suffer acute monocytic leukemia by Tsuchiya et 
al., 1980. THP-1 cell has become one of the most important and widely used cell line 
in the field of immunology particularly in the research regarding the function and 
regulation of monocytes and macrophages in cardiovascular system. This is due to the 
fact that, THP-1 cells have a very close resemblance to primary monocytes and 
macrophages in morphological and functional properties as well as in its 
differentiation markers (Kramer and Wray, 2002; Ueki et al., 2002). THP-1 cell show 
a round-single cell morphology that express distinct monocytic markers (Chanput et 
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al., 2015). Apart from that, THP-1 cell line is a type of immortalized cell line as it can 
be cultured in vitro for up to passage 25 without any changes in cell morphology and 
metabolic activity which benefit researchers as the cell stability is well-preserved 
(Chanput et al., 2014). Besides that, the usage of THP-1 cell line reduce the degree of 
variability in the cell phenotype due to its homogenous genetic background which 
provide advantage over the primary monocytes or macrophages in immune modulation 
approach (Aldo et al., 2013) 
The human monocytic cell line THP-1 can also be differentiated into THP-1 
derived macrophages, which display the same metabolic and morphological 
appearances. There are various differentiation agents used to differentiate THP-1 cells 
such as phorbol-12-myristate 13 acetate (PMA) and 1,25-dihydroxyvitamin D3 (VD3) 
(Daigneault et al., 2010a). Most of the THP-1 cells shown to adhere to culture plate as 
it start to change its morphology into flat and amoeboid shape with well-developed 
golgi apparatus, rough endoplasmic reticulum and ribosomes in the cell’s cytoplasm 
after the exposure to PMA as it undergoes differentiation process that display mature 
macrophages properties (Chanput et al., 2014). PMA treatment towards THP-1 cells 
activates protein kinase C (PKC) inducing a greater degree of differentiation 
(Daigneault et al., 2010a). PMA treated THP-1 cells was reported to generate a more 
mature macrophages phenotype with higher level of adherence, lower proliferation 
rate, higher phagocytic activity and a higher expression of CD11b, a cell surface 
marker of macrophages (Qin and Zhenyu, 2012; Schwende et al., 1996). In addition, 
according to Qin and Zhenyu, 2012, THP-1 cell and the differentiated THP-1 derived 
macrophages mimic the in situ alteration of monocyte and macrophages in 
atherosclerotic lesion which make it suitable to be used in the study of physiology and 
pathophysiology of cardiovascular diseases. Finally yet importantly, THP-1 cells are 
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the most widely used human monocyte-macrophages cell line in research related to 
atherosclerosis.  
1.5  Rationale of study 
Atherosclerosis is a worldwide epidemic and researchers must take action to 
find ways to reduce the risk factors contributing to it and come up with an appropriate 
treatment that poses no harm or adverse effect to human being. The pathogenesis of 
atherosclerosis involve specific immune response elicited by various effector cells that 
secrete numerous cytokines and enzymes and the proposed treatment for 
atherosclerosis must focus on a particular cell’s secretion such as pro-inflammatory 
cytokines in order to combat atherosclerosis.  
The usage of herbal or natural product is one of the suggested solution and 
propolis was utilized in this research to investigate its action on specific cells and its 
secretion. Propolis from different species in various geographic regions were reported 
to possess many biological attributes including anti-atherogenic contributed by its 
complex chemical constituents. However, to the best of our knowledge, there is no 
study conducted on propolis produced by Indo-malayan stingless bees particularly 
from Geniotrigona thoracica sp. of stingless bees. Indo-malayan stingless bees or 
lebah kelulut is one the most common type of bees found in Malaysia and the 
utilization of its bees product such as propolis in terms of scientific research for its 
therapeutic value particularly in atherosclerosis will give benefit to a wide range of 
people. Therefore, this study was conducted specifically to investigate the 
immunoregulatory role of propolis from Geniotrigona thoracica sp. of Indo-malayan 
stingless bees on the formation of foam cells in atherosclerosis development.  
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1.6 Objectives of study 
This study was conducted to investigate the effect of ethanolic extract of 
propolis (EEP) from Geniotrigona throracica sp. of stingless bees on the formation of       
THP-1 derived macrophage foam cells. 
 
The objectives of this study are listed below: 
1. To determine the bioactive compound of EEP from Geniotrigona throracica 
sp. of stingless bees. 
2. To determine the effect of EEP on the secretion of inflammatory cytokines by 
oxLDL treated macrophages.  
3. To determine the effect of EEP on the formation of lipid laden foam cells 
derived from oxidized LDL-treated macrophages. 
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CHAPTER 2  
MATERIALS AND METHODS 
2.1 Chemicals and suppliers 
The materials, antibodies, reagents, chemicals and commercial kits used in the study 
were listed in Table 2.1. 
 
Table 2.1 List of materials used in the study 
 
  
Materials Brand, Origin 
Cells: 
THP-1 cells 
 
ATCC, USA 
Cell Culture Media: 
Roswell Park Memorial Institute (RPMI) 1640 
Medium  
 
Gibco BRL, UK 
 
Antibody: 
APC-Cy 7 Mouse Anti-Human CD11b 
PE Rat Anti-Human CD115  
 
BD Pharmingen, USA 
BD Pharmingen, USA 
Reagents: 
Fetal Bovine Serum (FBS) 
Penicillin/Streptomycin 
Oxidized Low Density Lipoprotein (oxLDL), 
Human 
Phorbol 12-myristate 13-acetate (PMA) 
Presto Blue Viability Reagent 
Staining buffer 
 
Gibco BRL, UK 
Gibco BRL, UK 
Alfa Aesar, Thermo Fisher 
Scientific, UK 
Sigma Aldrich, USA 
Thermo Fisher Scientific, USA 
BD Pharmingen, USA 
BD Pharmingen, USA 
Chemicals: 
Oil Red O 
Haematoxylin  
2-propanol 
Formaldehyde 
Ethanol  
Dimethyl sulfoxide (DMSO) 
Methanol 
Acetonitrile 
Formic Acid 
Baicaline 
Hesperetin 
p-Coumaric Acid 
Caffeic acid 
 
Amresco, USA 
R&M Chemicals Ltd., USA 
QRec Asia 
Amresco, USA 
HmbG Chemicals, Germany 
Sigma Aldrich, USA 
Fisher Scientific, USA 
Fisher Scientific, USA 
Fisher Scientific, USA 
Toronto Chemicals, Canada 
Toronto Chemicals, Canada 
Toronto Chemicals, Canada 
Toronto Chemicals, Canada 
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Kaempferol 
Quercetin 
Naringenin 
 
Toronto Chemicals, Canada 
Toronto Chemicals, Canada 
Toronto Chemicals, Canada 
 
Commercial Kit: 
Cholesterol/Choletsryl Ester Quantitation Kit 
Human IL-1 beta ELISA Ready-Set-Go (2nd 
Generation kit 
Human TNF alpha ELISA Ready Set-Go Kit 
 
 
 
Abcam, UK 
Affymetrix, eBioscience, USA 
 
Affymetrix, eBioscience, USA 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1: Continued 
